Clinical Trial Update: Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops [Phase 3]

View source ↗

Summary

Phase 3 trial update examining ocular signs and symptoms when glaucoma patients switched from latanoprost to preservative-free tafluprost eye drops. Status: Com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Preservative-free Tafluprost eye drops (tafluprost)

Snippet

Sponsor: Santen Oy | Conditions: Ocular Hypertension, Open-Angle Glaucoma | Phase 3 | Status: COMPLETED